Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
, , , , 
Abstract
Share and Cite
Marretta, A.L.; Di Lorenzo, G.; Ribera, D.; Cannella, L.; von Arx, C.; Bracigliano, A.; Clemente, O.; Tafuto, R.; Pizzolorusso, A.; Tafuto, S. Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors. Pharmaceutics 2021, 13, 1522. https://doi.org/10.3390/pharmaceutics13091522
Marretta AL, Di Lorenzo G, Ribera D, Cannella L, von Arx C, Bracigliano A, Clemente O, Tafuto R, Pizzolorusso A, Tafuto S. Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors. Pharmaceutics. 2021; 13(9):1522. https://doi.org/10.3390/pharmaceutics13091522
Chicago/Turabian StyleMarretta, Antonella Lucia, Giuseppe Di Lorenzo, Dario Ribera, Lucia Cannella, Claudia von Arx, Alessandra Bracigliano, Ottavia Clemente, Roberto Tafuto, Antonio Pizzolorusso, and Salvatore Tafuto. 2021. "Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors" Pharmaceutics 13, no. 9: 1522. https://doi.org/10.3390/pharmaceutics13091522
APA StyleMarretta, A. L., Di Lorenzo, G., Ribera, D., Cannella, L., von Arx, C., Bracigliano, A., Clemente, O., Tafuto, R., Pizzolorusso, A., & Tafuto, S. (2021). Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors. Pharmaceutics, 13(9), 1522. https://doi.org/10.3390/pharmaceutics13091522
